Cathie Wood acquired 4.37 Million Verve Therapeutics shares worth $99.3 Million. That's 0.69% of their equity portfolio (27th largest holding). The investor owns 7.33% of the outstanding Verve Therapeutics stock. The investor's estimated purchase price is $153 Million, resulting in a loss of 35%.